Dofetilide

Major

Dofetilide Epinephrine An increased risk of cardiac arrhythmias Details Dofetilide Eribulin Halaven An increased risk of QT interval prolongation Details Dofetilide Erythromycin Erythrocin Stearate Increased dofetilide exposure and an increased risk of QT interval prolongation Details Dofetilide Escitalopram Lexapro An increased risk of QT interval prolongation Details Dofetilide Etrasimod Velsipity Increased risk of transient reduction in heart rate, AV conduction, QT interval prolongation and an increased risk of torsade de p... Details Dofetilide Famotidine Calmicid An increased risk of QT interval prolongation Details Dofetilide Fedratinib Inrebic Increased dofetilide exposure and an increased risk of dofetilide-related adverse events Details Dofetilide Felbamate Felbatol An increased risk of QT interval prolongation Details Dofetilide Fexinidazole Increased dofetilide exposure and an increased risk of QT interval prolongation Details Dofetilide Flecainide Tambocor® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Fluoxetine RECONCILE An increased risk of QT interval prolongation and an increased risk of torsades de pointes Details Dofetilide Formoterol Perforomist Increased risk of QT interval prolongation and an increased risk of cardiovascular adverse effects Details Dofetilide Foscarnet Foscavir An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Fosfomycin Contepo An increased risk of QT interval prolongation Details Dofetilide Fosnetupitant Increased exposure of CYP3A4 substrate Details Dofetilide Fosphenytoin Cerebyx An increased risk of QT interval prolongation Details Dofetilide Fostemsavir Rukobia Increased risk of torsade de pointes Details Dofetilide Galantamine Razadyne An increased risk of QT interval prolongation Details Dofetilide Gatifloxacin Zymaxid An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Gemifloxacin Factive An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Gepirone Exxua An increased risk of QT interval prolongation and cardiac arrhythmias Details Dofetilide Gepotidacin Blujepa Increased CYP3A4 substrate with NTI exposure and an increased risk of QT interval prolongation Details Dofetilide Gilteritinib Xospata Increased OCT1 substrate exposure and increased incidence and severity of adverse reactions associated with the OCT1 substrate Details Dofetilide Givinostat Duvyzat Increased risk of QT interval prolongation and torsade de pointes Details Dofetilide Glasdegib Daurismo Increased risk of QT interval prolongation Details Dofetilide Goserelin Increased risk of QT interval prolongation Details Dofetilide Granisetron An increased risk of QT interval prolongation Details Dofetilide Halofantrine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Haloperidol An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Halothane An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Histrelin Supprelin Increased risk of QT interval prolongation Details Dofetilide Hydroquinidine An increased risk of QT interval prolongation Details Dofetilide Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Dofetilide Hydroxyzine An increased risk of QT interval prolongation Details Dofetilide Ibutilide Corvert An increased risk of QT interval prolongation Details Dofetilide Iloperidone Fanapt An increased risk of QT interval prolongation Details Dofetilide Imatinib Gleevec Increased CYP3A4 substrate with NTI exposure and an increased risk of CYP3A4 substrates with NTI-related adverse reactions Details Dofetilide Imipramine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Dofetilide Inotuzumab Ozogamicin Besponsa Increased risk of QT interval prolongation Details Dofetilide Isoflurane Fluriso An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details